Industry Insights with Amy Sheng on Nanobodies: An Important Tool for the Next Generation of Tumor Diagnostics and Therapeutics
Amy Sheng shares how nanobodies are emerging as important tools for tumor diagnosis and treatment.
An Introduction to Infectious Disease Modeling
Hear ICON experts give an in-depth overview of infectious disease modeling with a focus on assessment of interventions and its challenges.
Industry Insights with Yuning Chen on Recombinant Proteins
Yuning Chen discusses The “ProVir™” collection and the role of recombinant virus proteins in the development of infectious disease treatment regimes and vaccines.
COVID-19 – What’s NMR got to do with it?
Dr. Sharman explains the impact of using NMR for the quality control and release of drug molecules currently in shortage due to the Coronavirus pandemic.
Comparability studies of Pharmaceutical Proteins by 2D NMR fingerprint
Dr. Malmstrøm demonstrates how correlations between NMR data and bioactivity can be used to confirm the structure and activity of proteins.
Micro-CT: Fancy gadget or indispensable technology towards accurate quantification of lung disease and therapy?
An infectious lung disease expert shares compelling evidence for the use of micro-CT to repeatedly evaluate disease progression and therapy efficacy in live animals.
Introduction to Antibodies and their Analytical Characterization
An expert from AstraZeneca will discuss the use of antibody drugs, how they function and the different techniques used to characterize them in the drug development process.
Infectious Disease Research: A Holistic Approach to Physiologic Data Collection and Model Development
Join Dr. Anna Honko and Dr. Doug Reed as they discuss methods and applications for infectious disease research including coronavirus-based illnesses.
